IPA ImmunoPrecise Antibodies Ltd Quick Liquidity Indicator

ImmunoPrecise - graphic logo of issuer IPA

The financial quote visualization for ImmunoPrecise Antibodies (IPA) on GURU.Markets shows a value of 1.82, while the company's growth is driving demand for the BioStrand system for digital antibody selection. The business is betting on B2B software sales to capture a niche in genetic engineering. The application of artificial intelligence allows for a significant acceleration in the development of oncology and viral infection drugs for major pharmaceutical plants.

ImmunoPrecise Antibodies Ltd. (IPA) Immediate Liquidity Ratio: for the period 07/04/2022 - 09/04/2025

Analytical breakdowns for ImmunoPrecise Antibodies (IPA)

- market value and analyst target forecast:
Price Chart immunoprecise.com|IPA - Consensus Target
- market capitalization data:
Market Valuation ImmunoPrecise|IPA - Enterprise Value
- book capitalization indicators:
Net Assets per Single Share ImmunoPrecise Antibodies|IPA - Accounting Capitalization|Market Value to Book Value Ratio immunoprecise.com|IPA - Company Assets
- debt and liquidity data:
Debt to Equity ImmunoPrecise Antibodies|IPA - Long-Term Liabilities to Equity|Short-Term Debt to Equity immunoprecise.com|IPA - Aggregate Debt Obligations|Debts to Book Capitalization ImmunoPrecise|IPA - Long-Term Debt|Company Short-Term Debts ImmunoPrecise Antibodies|Quick Ratio immunoprecise.com
- earnings and market multiples details:
IPA - Net Financial Result
Summary company analytics:ImmunoPrecise Antibodies Ltd - IPA
Manufactured product of immunoprecise.com

ImmunoPrecise Antibodies (IPA) brings together leading antibody engineers, supported by high-tech laboratory infrastructure in Europe and Canada. The quick ratio measures the company's ability to settle short-term debts using cash and accounts receivable, completely excluding low-liquidity inventories. For an investor, this is a critical marker of the business's financial stability and solvency. By analyzing the quick liquidity trend, one can assess the balance between operational safety and capital efficiency.

Analysis of competing companies

Tempus (TEM) - Quick Liquidity|Quick Liquidity Indicator Qiagen Corp|Quick Liquidity Indicator IONS|Quick Ratio repligen.com|Quick Liquidity Avidity Biosciences, Inc. (RNA)|CRISPR Therapeutics Inc - Immediate Liquidity Ratio|Quick Liquidity Sema4 WGS|Ultragenyx Corp (RARE) - Immediate Liquidity|BEAM - Quick Liquidity|Critical Liquidity Ratio SRPT|Twist Bioscience, Inc. (TWST) - Quick Liquidity|10x Genomics Inc - Intermediate Coverage Ratio|NTLA (Intellia) - Quick Ratio|Immediate Liquidity Stoke Corp STOK|Quick Ratio BLFS|Quick Liquidity Indicator wavelifesciences.com WVE|Quick Ratio MAZE (Maze Therapeutics)|Interim Coverage Ratio Sionna Therapeutics, Inc. (SION)|PRME - Quick Liquidity|Interim Coverage Ratio Taysha Corp TSHA|QURE: Quick Ratio|Immediate Liquidity meiragtx.com (MGTX)|Quick Liquidity Indicator RGNX|SLDB: Intermediate Coverage Ratio|Quick Ratio OCGN|Quick Ratio PacBio Corp (PACB)|Quick Liquidity Benitec Biopharma Inc. BNTC|DSGN: Immediate Liquidity Ratio|RCKT: Quick Liquidity Indicator|4DMT - Intermediate Liquidity Ratio|LXEO: Quick Ratio|KRRO - Interim Coverage Ratio|EDIT (Editas Medicine, Inc.) - Quick Ratio|Quick Liquidity SLN|Quick Liquidity ProQR Therapeutics N.V. (PRQR)|CDXS - Immediate Liquidity|Quick Ratio SGMO (Sangamo)|NAUT: Immediate Liquidity Ratio|Metagenomi, Inc. - Quick Ratio|Interim Coverage Ratio Precision BioSciences Inc. DTIL|GBIO: Quick Ratio|Immediate Liquidity Boundless Bio Inc. (BOLD)|Quick Liquidity Exicure Inc.|Celsion Corporation (IMNN) - Interim Coverage Ratio|Quick Ratio PHIO|Interim Coverage Ratio mustangbio.com|Quick Liquidity TransCode Therapeutics, Inc. RNAZ|BNGO (Bionano Genomics Inc.) - Critical Liquidity Ratio|Applied DNA - Quick Ratio|BLUE - Quick Ratio|OMGA: Quick Ratio|Immediate Liquidity Ratio OMIC|Quick Liquidity Regulus Therapeutics Inc.|Immediate Liquidity Ratio SYRS (Syros Pharmaceuticals Inc.)|Quick Ratio TBIO|Quick Ratio TRACON Pharmaceuticals, Inc (TCON)|Quick Ratio UBX (Unity Biotechnology)